Europe Dabigatran Etexilate Industry Market Research Report
SKU ID :Maia-14356761 | Published Date: 23-Jan-2020 | No. of pages: 94Description
TOC
1 Dabigatran Etexilate Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Dabigatran Etexilate
1.3 Dabigatran Etexilate Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Europe Dabigatran Etexilate Value and Growth Rate from 2014-2024
1.4 Market Segmentation
1.4.1 Types of Dabigatran Etexilate
1.4.2 Applications of Dabigatran Etexilate
1.4.3 Research Countries
1.5 Market Dynamics
1.5.1 Drivers
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Countries
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Dabigatran Etexilate Analysis
2.2 Major Players of Dabigatran Etexilate
2.2.1 Major Players Manufacturing Base and Market Share of Dabigatran Etexilate in 2018
2.2.2 Major Players Product Types in 2018
2.3 Dabigatran Etexilate Manufacturing Cost Structure Analysis
2.3.1 Consumption Process Analysis
2.3.2 Manufacturing Cost Structure of Dabigatran Etexilate
2.3.3 Raw Material Cost of Dabigatran Etexilate
2.3.4 Labor Cost of Dabigatran Etexilate
2.4 Market Channel Analysis of Dabigatran Etexilate
2.5 Major Downstream Buyers of Dabigatran Etexilate Analysis
3 Europe Dabigatran Etexilate Market, by Type
3.1 Europe Dabigatran Etexilate Value and Market Share by Type (2014-2019E)
3.2 Europe Dabigatran Etexilate Consumption and Market Share by Type (2014-2019E)
3.3 Europe Dabigatran Etexilate Value and Growth Rate by Type (2014-2019E)
3.3.1 Europe Dabigatran Etexilate Value and Growth Rate of 110mg capsules
3.3.2 Europe Dabigatran Etexilate Value and Growth Rate of 150mg capsules
3.3.3 Europe Dabigatran Etexilate Value and Growth Rate of Others
3.4 Europe Dabigatran Etexilate Price Analysis by Type (2014-2019E)
4 Dabigatran Etexilate Market, by Application
4.1 Downstream Market Overview
4.2 Europe Dabigatran Etexilate Consumption and Market Share by Application (2014-2019E)
4.2.1 Europe Dabigatran Etexilate Consumption and Growth Rate of Clinical (2014-2019E)
4.2.2 Europe Dabigatran Etexilate Consumption and Growth Rate of Hospital (2014-2019E)
4.2.3 Europe Dabigatran Etexilate Consumption and Growth Rate of Personal (2014-2019E)
5 Europe Dabigatran Etexilate Consumption, Value ($) by Countries (2014-2019E)
5.1 Europe Dabigatran Etexilate Value and Market Share by Countries (2014-2019E)
5.2 Europe Dabigatran Etexilate Consumption and Market Share by Countries (2014-2019E)
5.3 Europe Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
5.4 Germany Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
5.5 UK Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
5.6 France Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
5.7 Italy Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
5.8 Spain Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
5.9 Russia Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
6 Competitive Landscape
6.1 Competitive Profile
6.2 Bayer Healthcare AG (Germany)
6.2.1 Company Profiles
6.2.2 Dabigatran Etexilate Product Introduction
6.2.3 Bayer Healthcare AG (Germany) Sales, Value, Price, Gross Margin 2014-2019E
6.2.4 Bayer Healthcare AG (Germany) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.3 Sanofi S.A. (France)
6.3.1 Company Profiles
6.3.2 Dabigatran Etexilate Product Introduction
6.3.3 Sanofi S.A. (France) Sales, Value, Price, Gross Margin 2014-2019E
6.3.4 Sanofi S.A. (France) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.4 Eisai Inc. (US)
6.4.1 Company Profiles
6.4.2 Dabigatran Etexilate Product Introduction
6.4.3 Eisai Inc. (US) Sales, Value, Price, Gross Margin 2014-2019E
6.4.4 Eisai Inc. (US) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.5 Aspen Holdings (South Africa)
6.5.1 Company Profiles
6.5.2 Dabigatran Etexilate Product Introduction
6.5.3 Aspen Holdings (South Africa) Sales, Value, Price, Gross Margin 2014-2019E
6.5.4 Aspen Holdings (South Africa) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.6 Mitsubishi Tanabe Pharma Corporation (Japan)
6.6.1 Company Profiles
6.6.2 Dabigatran Etexilate Product Introduction
6.6.3 Mitsubishi Tanabe Pharma Corporation (Japan) Sales, Value, Price, Gross Margin 2014-2019E
6.6.4 Mitsubishi Tanabe Pharma Corporation (Japan) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.7 Abbott India Limited (India)
6.7.1 Company Profiles
6.7.2 Dabigatran Etexilate Product Introduction
6.7.3 Abbott India Limited (India) Sales, Value, Price, Gross Margin 2014-2019E
6.7.4 Abbott India Limited (India) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.8 Bristol-Myers Squibb Company (US)
6.8.1 Company Profiles
6.8.2 Dabigatran Etexilate Product Introduction
6.8.3 Bristol-Myers Squibb Company (US) Sales, Value, Price, Gross Margin 2014-2019E
6.8.4 Bristol-Myers Squibb Company (US) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.9 GlaxoSmithKline Plc. (UK)
6.9.1 Company Profiles
6.9.2 Dabigatran Etexilate Product Introduction
6.9.3 GlaxoSmithKline Plc. (UK) Sales, Value, Price, Gross Margin 2014-2019E
6.9.4 GlaxoSmithKline Plc. (UK) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.10 Pfizer, Inc. (US)
6.10.1 Company Profiles
6.10.2 Dabigatran Etexilate Product Introduction
6.10.3 Pfizer, Inc. (US) Sales, Value, Price, Gross Margin 2014-2019E
6.10.4 Pfizer, Inc. (US) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.11 Teva Pharmaceutical Industries Ltd. (Israel)
6.11.1 Company Profiles
6.11.2 Dabigatran Etexilate Product Introduction
6.11.3 Teva Pharmaceutical Industries Ltd. (Israel) Sales, Value, Price, Gross Margin 2014-2019E
6.11.4 Teva Pharmaceutical Industries Ltd. (Israel) Market Share of Dabigatran Etexilate Segmented by Region in 2018
6.12 Boehringer Ingelheim (Germany)
6.12.1 Company Profiles
6.12.2 Dabigatran Etexilate Product Introduction
6.12.3 Boehringer Ingelheim (Germany) Sales, Value, Price, Gross Margin 2014-2019E
6.12.4 Boehringer Ingelheim (Germany) Market Share of Dabigatran Etexilate Segmented by Region in 2018
7 Europe Dabigatran Etexilate Market Analysis and Forecast by Type and Application
7.1 Europe Dabigatran Etexilate Market Value & Volume Forecast, by Type (2019-2024)
7.1.1 110mg capsules Market Value and Volume Forecast (2019-2024)
7.1.2 150mg capsules Market Value and Volume Forecast (2019-2024)
7.1.3 Others Market Value and Volume Forecast (2019-2024)
7.2 Europe Dabigatran Etexilate Market Value & Volume Forecast, by Application (2019-2024)
7.2.1 Clinical Market Value and Volume Forecast (2019-2024)
7.2.2 Hospital Market Value and Volume Forecast (2019-2024)
7.2.3 Personal Market Value and Volume Forecast (2019-2024)
8 Dabigatran Etexilate Market Analysis and Forecast by Countries
8.1 Germany Market Value and Consumption Forecast (2019-2024)
8.2 UK Market Value and Consumption Forecast (2019-2024)
8.3 France Market Value and Consumption Forecast (2019-2024)
8.4 Italy Market Value and Consumption Forecast (2019-2024)
8.5 Spain Market Value and Consumption Forecast (2019-2024)
8.6 Russia Market Value and Consumption Forecast (2019-2024)
9 New Project Feasibility Analysis
9.1 Industry Barriers and New Entrants SWOT Analysis
9.2 Analysis and Suggestions on New Project Investment
10 Research Finding and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Tables & Figures
List of Tables and Figures
Figure Product Picture of Dabigatran Etexilate
Table Product Specification of Dabigatran Etexilate
Figure Market Concentration Ratio and Market Maturity Analysis of Dabigatran Etexilate
Figure Europe Dabigatran Etexilate Value ($) and Growth Rate from 2014-2024
Table Different Types of Dabigatran Etexilate
Figure Europe Dabigatran Etexilate Value ($) Segment by Type from 2014-2019E
Figure Europe Dabigatran Etexilate Market Share by Types in 2018
Figure 110mg capsules Picture
Figure 150mg capsules Picture
Figure Others Picture
Table Different Applications of Dabigatran Etexilate
Figure Europe Dabigatran Etexilate Value ($) Segment by Applications from 2014-2019E
Figure Europe Dabigatran Etexilate Market Share by Applications in 2018
Figure Clinical Picture
Figure Hospital Picture
Figure Personal Picture
Table Research Countries of Dabigatran Etexilate
Figure Europe Dabigatran Etexilate Market Share by Countries in 2018
Figure Germany Dabigatran Etexilate Consumption Value ($) and Growth Rate (2014-2019E)
Figure UK Dabigatran Etexilate Consumption Value ($) and Growth Rate (2014-2019E)
Figure France Dabigatran Etexilate Consumption Value ($) and Growth Rate (2014-2019E)
Figure Italy Dabigatran Etexilate Consumption Value ($) and Growth Rate (2014-2019E)
Figure Spain Dabigatran Etexilate Consumption Value ($) and Growth Rate (2014-2019E)
Figure Russia Dabigatran Etexilate Consumption Value ($) and Growth Rate (2014-2019E)
Table Emerging and Growing Market of Dabigatran Etexilate
Table Industry News
Table Industry Policies
Figure Industry Chain Analysis of Dabigatran Etexilate
Table Upstream Raw Material Suppliers of Dabigatran Etexilate with Contact Information
Table Major Players Manufacturing Base and Market Share of Dabigatran Etexilate in 2018
Table Major Players Consumption Value Market Share of Dabigatran Etexilate in 2018
Table Major Players Dabigatran Etexilate Product Types in 2018
Figure Consumption Process of Dabigatran Etexilate
Figure Manufacturing Cost Structure of Dabigatran Etexilate
Figure Channel Status of Dabigatran Etexilate
Table Major Distributors of Dabigatran Etexilate with Contact Information
Table Major Downstream Buyers of Dabigatran Etexilate with Contact Information
Table Europe Dabigatran Etexilate Value ($) by Type (2014-2019E)
Table Europe Dabigatran Etexilate Value Share by Type (2014-2019E)
Figure Europe Dabigatran Etexilate Value Share by Type (2014-2019E)
Table Europe Dabigatran Etexilate Consumption by Type (2014-2019E)
Table Europe Dabigatran Etexilate Consumption Share by Type (2014-2019E)
Figure Europe Dabigatran Etexilate Consumption Share by Type (2014-2019E)
Figure 110mg capsules Picture
Figure 150mg capsules Picture
Figure Others Picture
Figure Europe Dabigatran Etexilate Value ($) and Growth Rate of Others
Table Europe Dabigatran Etexilate Price by Type (2014-2019E)
Figure Downstream Market Overview
Table Europe Dabigatran Etexilate Consumption by Application (2014-2019E)
Table Europe Dabigatran Etexilate Consumption Market Share by Application (2014-2019E)
Figure Europe Dabigatran Etexilate Consumption Market Share by Application (2014-2019E)
Figure Europe Dabigatran Etexilate Consumption and Growth Rate of Clinical (2014-2019)
Figure Europe Dabigatran Etexilate Consumption and Growth Rate of Hospital (2014-2019)
Figure Europe Dabigatran Etexilate Consumption and Growth Rate of Personal (2014-2019)
Table Europe Dabigatran Etexilate Value ($) by Countries (2014-2019E)
Table Europe Dabigatran Etexilate Value Market Share by Countries (2014-2019E)
Figure Europe Dabigatran Etexilate Value Market Share by Countries (2014-2019E)
Table Europe Dabigatran Etexilate Consumption by Countries (2014-2019E)
Table Europe Dabigatran Etexilate Consumption Market Share by Countries (2014-2019E)
Figure Europe Dabigatran Etexilate Consumption Market Share by Countries (2014-2019E)
Table Europe Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
Table Germany Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
Table UK Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
Table France Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
Table Italy Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
Table Spain Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
Table Russia Dabigatran Etexilate Consumption, Value, Price and Gross Margin (2014-2019E)
Figure Top 3 Market Share of Dabigatran Etexilate Companies in 2018
Figure Top 6 Market Share of Dabigatran Etexilate Companies in 2018
Table Major Players Value ($) Share (2014-2019E)
Table Company Profiles
Table Product Introduction
Table Bayer Healthcare AG (Germany) Sales, Value, Price, Gross Margin 2014-2019E
Figure Bayer Healthcare AG (Germany) Sales and Growth Rate
Figure Bayer Healthcare AG (Germany) Value ($) Market Share 2014-2019
Figure Bayer Healthcare AG (Germany) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Sanofi S.A. (France) Sales, Value, Price, Gross Margin 2014-2019E
Figure Sanofi S.A. (France) Sales and Growth Rate
Figure Sanofi S.A. (France) Value ($) Market Share 2014-2019
Figure Sanofi S.A. (France) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Eisai Inc. (US) Sales, Value, Price, Gross Margin 2014-2019E
Figure Eisai Inc. (US) Sales and Growth Rate
Figure Eisai Inc. (US) Value ($) Market Share 2014-2019
Figure Eisai Inc. (US) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Aspen Holdings (South Africa) Sales, Value, Price, Gross Margin 2014-2019E
Figure Aspen Holdings (South Africa) Sales and Growth Rate
Figure Aspen Holdings (South Africa) Value ($) Market Share 2014-2019
Figure Aspen Holdings (South Africa) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Mitsubishi Tanabe Pharma Corporation (Japan) Sales, Value, Price, Gross Margin 2014-2019E
Figure Mitsubishi Tanabe Pharma Corporation (Japan) Sales and Growth Rate
Figure Mitsubishi Tanabe Pharma Corporation (Japan) Value ($) Market Share 2014-2019
Figure Mitsubishi Tanabe Pharma Corporation (Japan) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Abbott India Limited (India) Sales, Value, Price, Gross Margin 2014-2019E
Figure Abbott India Limited (India) Sales and Growth Rate
Figure Abbott India Limited (India) Value ($) Market Share 2014-2019
Figure Abbott India Limited (India) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Bristol-Myers Squibb Company (US) Sales, Value, Price, Gross Margin 2014-2019E
Figure Bristol-Myers Squibb Company (US) Sales and Growth Rate
Figure Bristol-Myers Squibb Company (US) Value ($) Market Share 2014-2019
Figure Bristol-Myers Squibb Company (US) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table GlaxoSmithKline Plc. (UK) Sales, Value, Price, Gross Margin 2014-2019E
Figure GlaxoSmithKline Plc. (UK) Sales and Growth Rate
Figure GlaxoSmithKline Plc. (UK) Value ($) Market Share 2014-2019
Figure GlaxoSmithKline Plc. (UK) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Pfizer, Inc. (US) Sales, Value, Price, Gross Margin 2014-2019E
Figure Pfizer, Inc. (US) Sales and Growth Rate
Figure Pfizer, Inc. (US) Value ($) Market Share 2014-2019
Figure Pfizer, Inc. (US) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Teva Pharmaceutical Industries Ltd. (Israel) Sales, Value, Price, Gross Margin 2014-2019E
Figure Teva Pharmaceutical Industries Ltd. (Israel) Sales and Growth Rate
Figure Teva Pharmaceutical Industries Ltd. (Israel) Value ($) Market Share 2014-2019
Figure Teva Pharmaceutical Industries Ltd. (Israel) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Company Profiles
Table Product Introduction
Table Boehringer Ingelheim (Germany) Sales, Value, Price, Gross Margin 2014-2019E
Figure Boehringer Ingelheim (Germany) Sales and Growth Rate
Figure Boehringer Ingelheim (Germany) Value ($) Market Share 2014-2019
Figure Boehringer Ingelheim (Germany) Market Share of Dabigatran Etexilate Segmented by Region in 2018
Table Europe Dabigatran Etexilate Market Value ($) Forecast, by Type
Table Europe Dabigatran Etexilate Market Volume Forecast, by Type
Table Europe Market Value ($) Forecast by Application (2019-2024)
Table Europe Market Volume Forecast by Application (2019-2024)
Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024)
Figure Germany Consumption and Growth Rate Forecast (2019-2024)
Figure UK Market Value ($) and Growth Rate Forecast (2019-2024)
Figure UK Consumption and Growth Rate Forecast (2019-2024)
Figure France Market Value ($) and Growth Rate Forecast (2019-2024)
Figure France Consumption and Growth Rate Forecast (2019-2024)
Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024)
Figure Italy Consumption and Growth Rate Forecast (2019-2024)
Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024)
Figure Spain Consumption and Growth Rate Forecast (2019-2024)
Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024)
Figure Russia Consumption and Growth Rate Forecast (2019-2024)
Figure Industry Resource/Technology/Labor Importance Analysis
Table New Entrants SWOT Analysis
Table New Project Analysis of Investment Recovery
Companies
- PRICE
-
$3440$4500